Utilizing tissues from subjects with renal cell cancer (RCC) and CRC, researchers discovered that cancers with the most potent HIF1 function were those lacking Vit-C in the tumor microenvironment (TME) [140,141,142,143]. This evidence concerns the gene HIF1A and renal cell adenocarcinoma.